News
AXGN
16.48
-0.06%
-0.01
Weekly Report: what happened at AXGN last week (1223-1227)?
Weekly Report · 12/30/2024 11:32
AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?
NASDAQ · 12/24/2024 14:15
Weekly Report: what happened at AXGN last week (1216-1220)?
Weekly Report · 12/23/2024 11:39
SNN Stock May Gain on CORIOGRAPH Platform's FDA Clearance for THA
NASDAQ · 12/20/2024 14:03
ARAY Stock Falls Despite Positive Data of CyberKnife in Treating BSM
NASDAQ · 12/19/2024 14:19
DaVita Stock Gains 40.1% Year to Date: What's Behind the Rally?
NASDAQ · 12/19/2024 12:42
DXCM Stock Gains on the Launch of Proprietary Generative AI Platform
NASDAQ · 12/18/2024 15:34
Here's Why you Should Retain Veeva Systems Stock in Your Portfolio Now
NASDAQ · 12/17/2024 13:04
Here's Why you Should Retain Nevro Stock in Your Portfolio Now
NASDAQ · 12/17/2024 13:03
Weekly Report: what happened at AXGN last week (1209-1213)?
Weekly Report · 12/16/2024 11:41
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
NASDAQ · 12/13/2024 12:56
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now
NASDAQ · 12/13/2024 12:54
Here's Why You Should Add Glaukos Stock to Your Portfolio Now
Barchart · 12/11/2024 08:50
Here's Why You Should Add Accuray Stock in Your Portfolio Now
Barchart · 12/10/2024 11:14
HealthEquity Stock Falls Despite Q3 Earnings and Revenue Beat
Barchart · 12/10/2024 11:14
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now
NASDAQ · 12/09/2024 18:04
Weekly Report: what happened at AXGN last week (1202-1206)?
Weekly Report · 12/09/2024 11:39
Strength Across Segments to Help CAH Stock Offset OptumRx Headwind?
NASDAQ · 12/05/2024 12:50
Reasons to Retain Inari Medical Stock in Your Portfolio for Now
NASDAQ · 12/04/2024 12:46
More
Webull provides a variety of real-time AXGN stock news. You can receive the latest news about Axogen Inc through multiple platforms. This information may help you make smarter investment decisions.
About AXGN
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its products include Avance nerve graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Axotouch Two-Point Discriminator and Axoguard HA+ Nerve Protector. Avance nerve graft is a biologically active processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. Axoguard Nerve Connector is a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce nerve reconstruction while preventing soft tissue attachment. Axotouch Two-Point Discriminator is used to measure the innervation density of any surface area of the skin.